Short-Supply Prescription Drugs: Shining a Light on the Gray Market

July 25, 2012

253 Russell Senate Office Building

Consumer Protection 2WASHINGTON, D.C.—The U.S. Senate Committee on Commerce, Science, and Transportation will hold a hearing examining the so-called “gray market” drug companies who drive up the cost of short-supply prescription drugs. The hearing will explore how and why hospitals and other health care providers sometimes struggle to obtain short-supply prescription drugs they need to treat patients suffering from cancer and other life-threatening conditions.  This hearing is the result of a joint Congressional investigation by Chairman John D. (Jay) Rockefeller IV, Senator Tom Harkin, Chairman of the Senate Committee on Health, Education, Labor, and Pensions, and Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform.

Please note the hearing will be webcast live via the Senate Commerce Committee website.  Refresh the Commerce Committee homepage 10 minutes prior to the scheduled start time to automatically begin streaming the webcast.

Individuals with disabilities who require an auxiliary aid or service, including closed captioning service for webcast hearings, should contact Collenne Wider at 202-224-5511 at least three business days in advance of the hearing date.



Majority Statement

  • Senator John D. (Jay) Rockefeller IV

    U.S. Senate Committee on Commerce, Science, and Transportation

Witness Panel 1

  • Honorable Elijah E. Cummings

    Ranking Member
    U.S. House Committee on Oversight and Government Reform

Witness Panel 2

  • Ms. Virginia Herold

    Executive Officer
    California Board of Pharmacy
    Herald Testimony (121.05 KB)
  • Dr. David Mayhaus

    Chief Pharmacy Director
    Cincinnati Children's Hospital Medical Center
  • Dr. John Coster

    Senior Vice President of Government Affairs and Director, NCPA Advocacy Center
    National Community Pharmacists Association
    Coster Testimony (313.84 KB)
  • Mr. John Gray

    President and CEO
    Healthcare Distribution Management Association
    Gray Testimony (72.48 KB)
  • Ms. Patricia Earl

    Industry Analyst
    National Coalition of Pharmaceutical Distributors
    Earl Testimony (208.28 KB)